Crohn's disease clinical course and severity in obese patients

Clinical Nutrition

Volumn 21, Issue 1, 2002, Pages 51-57

  Braga, M ^a   Gianotti, L ^a,b   Gentilini, O ^a   Liotta, S ^a   Di Carlo, V ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Anoperineal fistula; Crohn's disease; Immunosuppressants; Obesity

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; METHOTREXATE;

ADULT; AGE; ANUS DISEASE; ANUS FISTULA; ARTICLE; BODY MASS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OBESITY; PERIANAL ABSCESS; RETROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 0036209411     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2001.0503     Document Type: Article

References (34)

1. Nutritional considerations in inflammatory bowel diseases
2. Total energy expenditure in patients with Crohn's disease: Measurement by the combined body scan technique
3. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption
4. Energy and substrate metabolism in patients with active Crohn's disease
5. Elevated diet-induced thermogenesis and lipid oxidation rate in Crohn disease
6. Energy metabolism and substrate oxidation in patients with Crohn's disease
7. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission
8. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls
9. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: Results from a primary care-based incident case-control study in Norfolk, England
10. Weight reduction in obese patients with rheumatoid arthritis, with preservation of body cell mass and improvement of physical fitness
11. Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: A quality improvement study
12. Fat-wrapping in Crohn's disease: Pathological basis and relevance to surgical practice
13. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease
14. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro
15. Establishing a standard definition for child overweight and obesity worldwide: International survey
16. Classification of inflammatory bowel disease
17. A simple classification of Crohn's disease: Report of the working party for the world congresses of gastroenterology, Vienna 1998
18. Respective effects of current and former cigarette smoking on the clinical course of Crohn's disease
19. Classification of the sequelae of bowel resection for Crohn's disease
20. Obesity: Epidemiology and public health
21. Pre-illness dietary factors in inflammatory bowel disease
22. Twenty-four-hour energy balance in Crohn disease patients: Metabolic implications of steroid treatment
23. Growth failure in chronic inflammatory bowel disease: A prospective study
24. Energy expenditure and body composition in children with Crohn's disease: Effect of enteral nutrition and treatment with prednisolone
25. Serum leptin in children and young adults with inflammatory bowel disease
26. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
27. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
28. Infliximab for the treatment of fistulas in patients with Crohn's disease
29. Linkage heterogeneity for the IBDl locus in Crohn's disease pedigrees by disease onset and severity
30. Effect of cigarette smoking on the long-term course of Crohn's disease
31. An immunologic mechanism for the association between obesity and asthma
32. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway
33. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity
34. Plasminogen activator inhibitor 1, transforming growth factor-betal, and BMI are closely associated in human adipose tissue during morbid obesity